TAMOXIFEN AS TREATMENT FOR GYNECOMASTIA AND MASTODYNIA RESULTING FROM HORMONAL DEPRIVATION

Abstract

No AccessJournal of UrologyClinical Urology: Case Reports1 Apr 1998TAMOXIFEN AS TREATMENT FOR GYNECOMASTIA AND MASTODYNIA RESULTING FROM HORMONAL DEPRIVATION SCOTT SERELS and ARNOLD MELMAN SCOTT SERELSSCOTT SERELS More articles by this author and ARNOLD MELMANARNOLD MELMAN More articles by this author View All Author Informationhttps://doi.org/10.1016/S0022-5347(01)63595-XAboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail "TAMOXIFEN AS TREATMENT FOR GYNECOMASTIA AND MASTODYNIA RESULTING FROM HORMONAL DEPRIVATION." The Journal of Urology, 159(4), p. 1309 References 1 : A controlled trial of leuprolide with and without flutamide in prostatic carcinoma. New Engl. J. Med.1989; 321: 419. Google Scholar 2 : Leuprolide versus diethylstilbestrol for metastatic prostate cancer. New Engl. J. Med.1984; 311: 1281. Google Scholar 3 : Studies of tamoxifen in women with mastalgia. Brit. J. Clin. Pract., suppl.1989; 68: 34. Google Scholar Department of Urology, Montefiore Medical Center, Bronx, New York.© 1998 by American Urological Association, Inc.FiguresReferencesRelatedDetailsCited byDOBS A and DARKES M (2018) INCIDENCE AND MANAGEMENT OF GYNECOMASTIA IN MEN TREATED FOR PROSTATE CANCERJournal of Urology, VOL. 174, NO. 5, (1737-1742), Online publication date: 1-Nov-2005. Volume 159Issue 4April 1998Page: 1309 Advertisement Copyright & Permissions© 1998 by American Urological Association, Inc.MetricsAuthor Information SCOTT SERELS More articles by this author ARNOLD MELMAN More articles by this author Expand All Advertisement PDF downloadLoading ...